Bausch + Lomb (BLCO) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free BLCO Stock Alerts $14.79 +0.03 (+0.20%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBausch + Lomb reports positive study results for Blink NutriTearsmsn.com - April 25 at 2:19 PMBausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyesbusinesswire.com - April 25 at 8:30 AMBausch + Lomb (BLCO) Set to Announce Quarterly Earnings on Wednesdayamericanbankingnews.com - April 24 at 5:16 AMBausch + Lomb (NYSE:BLCO) Price Target Cut to $18.00americanbankingnews.com - April 23 at 4:40 AMAnalysts Are Bullish on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Edgewise Therapeutics (EWTX)markets.businessinsider.com - April 22 at 4:11 PMRoyal Bank of Canada Cuts Bausch + Lomb (NYSE:BLCO) Price Target to $18.00marketbeat.com - April 22 at 12:12 PMBausch + Lomb Corporation (BLCO)finance.yahoo.com - April 18 at 1:42 PMBausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programsbusinesswire.com - April 18 at 7:00 AMBausch + Lomb Co. (NYSE:BLCO) Shares Purchased by River Road Asset Management LLCmarketbeat.com - April 17 at 4:41 PMBausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1businesswire.com - April 15 at 12:00 PMBausch Health gains after appeals court affirms ruling in Norwich patent case (update)msn.com - April 11 at 3:26 PMBausch + Lomb (NYSE:BLCO) Sees Unusually-High Trading Volumemarketbeat.com - April 11 at 2:49 PMBausch + Lomb’s Strong Market Position and Innovative Pipeline Justify Buy Ratingmarkets.businessinsider.com - April 9 at 3:37 PMBausch + Lomb (NYSE:BLCO) PT Raised to $17.00 at Evercore ISImarketbeat.com - April 4 at 12:44 PMBausch + Lomb’s Strong Position in Dry Eye Market Prompts Buy Ratingmarkets.businessinsider.com - April 2 at 1:44 PMShort Interest in Bausch + Lomb Co. (NYSE:BLCO) Decreases By 20.1%marketbeat.com - March 30 at 4:44 PMBLCO Crosses Above Key Moving Average Levelnasdaq.com - March 29 at 10:53 AMBLCO Apr 2024 17.500 callfinance.yahoo.com - March 16 at 9:52 AMBausch + Lomb Co. (NYSE:BLCO) Receives Average Recommendation of "Moderate Buy" from Analystsmarketbeat.com - March 11 at 2:15 AMBenchmark upgrades Emergent Biosolutions to Buymsn.com - March 7 at 12:16 PMLaurion Capital Management LP Lowers Holdings in Bausch + Lomb Co. (NYSE:BLCO)marketbeat.com - March 4 at 1:35 PMBausch + Lomb Co. (NYSE:BLCO) Shares Bought by Alberta Investment Management Corpmarketbeat.com - March 1 at 4:23 PMBausch + Lomb Announces Appointment of Karen L. Ling to Board of Directorsfinance.yahoo.com - February 28 at 8:09 AMConnor Clark & Lunn Investment Management Ltd. Invests $5.09 Million in Bausch + Lomb Co. (NYSE:BLCO)marketbeat.com - February 27 at 7:34 AMBarclays Maintains Equal-Weight Rating for Bausch & Lomb: Here's What You Need To Knowmarkets.businessinsider.com - February 26 at 1:40 PMAnalysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Bausch + Lomb Corporation (BLCO) and Eli Lilly & Co (LLY)markets.businessinsider.com - February 26 at 8:39 AMBausch + Lomb (NYSE:BLCO) Price Target Raised to $18.00 at Barclaysmarketbeat.com - February 26 at 8:12 AMBausch + Lomb Stock Jumps After Better-Than-Expected Earnings, Guidancemsn.com - February 23 at 12:30 PMBausch + Lomb Co. (NYSE:BLCO) Expected to Earn Q3 2024 Earnings of $0.19 Per Sharemarketbeat.com - February 23 at 7:33 AMBausch + Lomb Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - February 23 at 7:29 AMBHC Feb 2024 10.000 putfinance.yahoo.com - February 22 at 9:28 PMBausch + Lomb Corporation (NYSE:BLCO) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 22 at 1:12 PMBausch + Lomb (NYSE:BLCO) Price Target Raised to $23.00marketbeat.com - February 22 at 10:38 AMBausch + Lomb price target raised by $2 at Wells Fargo, here's whyrealmoney.thestreet.com - February 22 at 1:46 AMQ4 2023 Bausch + Lomb Corp Earnings Callfinance.yahoo.com - February 22 at 1:46 AMNeedham Reaffirms Their Hold Rating on Bausch + Lomb Corporation (BLCO)markets.businessinsider.com - February 21 at 8:46 PMBausch & Lomb’s stock soars 9% after earnings beatmsn.com - February 21 at 8:46 PMEye Care-Focused Bausch + Lomb's Stock Surges On Upbeat Annual Guidance Despite Deeper Lossesmsn.com - February 21 at 3:46 PMBausch & Lomb’s stock soars 11% after earnings beatmsn.com - February 21 at 3:46 PMEmergent appoints former Bausch + Lomb CEO to head companyreuters.com - February 21 at 3:46 PMBLCO Earnings: Bausch + Lomb Outperforms in Q4, Shares Jumpmsn.com - February 21 at 3:46 PMBausch + Lomb gains after earnings beatmsn.com - February 21 at 3:46 PMBausch + Lomb (NYSE:BLCO) Shares Gap Up After Better-Than-Expected Earningsmarketbeat.com - February 21 at 10:26 AMBausch + Lomb (NYSE:BLCO) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPSmarketbeat.com - February 21 at 8:42 AMEmergent BioSolutions Appoints Joseph Papa As President And CEOmarkets.businessinsider.com - February 21 at 8:15 AMBausch + Lomb Q4 Adj. Net Income Risesmarkets.businessinsider.com - February 21 at 8:15 AMBausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidancefinance.yahoo.com - February 21 at 8:15 AMEmergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEOfinance.yahoo.com - February 21 at 8:15 AMBausch & Lomb Corp (BLCO) Reports Robust Revenue Growth Amidst Net Loss in Q4 and Full-Year 2023finance.yahoo.com - February 21 at 8:15 AMBausch + Lomb Corporation 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - February 21 at 8:13 AM Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. BLCO Media Mentions By Week BLCO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCO News Sentiment▼-0.280.32▲Average Medical News Sentiment BLCO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCO Articles This Week▼83▲BLCO Articles Average Week Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: STAAR Surgical News Today RxSight News Today National Vision News Today Warby Parker News Today Cooper Companies News Today Option Care Health News Today Glaukos News Today Halozyme Therapeutics News Today Blueprint Medicines News Today CRISPR Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BLCO) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch + Lomb Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
